These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
712 related items for PubMed ID: 11841694
21. C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis. Jégou JF, Chan P, Schouft MT, Griffiths MR, Neal JW, Gasque P, Vaudry H, Fontaine M. J Immunol; 2007 Mar 01; 178(5):3323-31. PubMed ID: 17312184 [Abstract] [Full Text] [Related]
22. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. Okuda Y, Sakoda S, Fujimura H, Saeki Y, Kishimoto T, Yanagihara T. J Neuroimmunol; 1999 Nov 15; 101(2):188-96. PubMed ID: 10580801 [Abstract] [Full Text] [Related]
23. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. Oliver AR, Lyon GM, Ruddle NH. J Immunol; 2003 Jul 01; 171(1):462-8. PubMed ID: 12817031 [Abstract] [Full Text] [Related]
24. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Tohoku J Exp Med; 2007 Dec 01; 213(4):329-39. PubMed ID: 18075237 [Abstract] [Full Text] [Related]
25. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. Bettelli E, Baeten D, Jäger A, Sobel RA, Kuchroo VK. J Clin Invest; 2006 Sep 01; 116(9):2393-402. PubMed ID: 16955141 [Abstract] [Full Text] [Related]
26. A critical role for lymphotoxin in experimental allergic encephalomyelitis. Suen WE, Bergman CM, Hjelmström P, Ruddle NH. J Exp Med; 1997 Oct 20; 186(8):1233-40. PubMed ID: 9334362 [Abstract] [Full Text] [Related]
27. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE). Offen D, Kaye JF, Bernard O, Merims D, Coire CI, Panet H, Melamed E, Ben-Nun A. J Mol Neurosci; 2000 Dec 20; 15(3):167-76. PubMed ID: 11303781 [Abstract] [Full Text] [Related]
28. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Crocker SJ, Whitmire JK, Frausto RF, Chertboonmuang P, Soloway PD, Whitton JL, Campbell IL. Am J Pathol; 2006 Dec 20; 169(6):2104-16. PubMed ID: 17148673 [Abstract] [Full Text] [Related]
29. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA, Ramsbottom MJ, Cross AH. Eur J Immunol; 2002 Jul 20; 32(7):1905-13. PubMed ID: 12115610 [Abstract] [Full Text] [Related]
30. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Okuda Y, Okuda M, Bernard CC. Immunol Lett; 2002 Apr 01; 81(1):25-9. PubMed ID: 11841842 [Abstract] [Full Text] [Related]
31. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. von Büdingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, Genain CP. J Clin Immunol; 2001 May 01; 21(3):155-70. PubMed ID: 11403222 [Abstract] [Full Text] [Related]
32. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S. Am J Pathol; 2006 Mar 01; 168(3):812-21. PubMed ID: 16507897 [Abstract] [Full Text] [Related]
33. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD. J Immunol; 2002 Apr 15; 168(8):4173-83. PubMed ID: 11937578 [Abstract] [Full Text] [Related]
34. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, Strijkers GJ, Laman JD, Hintzen RQ, Bauer J, Brok HP, 't Hart BA. J Immunol; 2008 Feb 01; 180(3):1326-37. PubMed ID: 18209026 [Abstract] [Full Text] [Related]
35. The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice. Liñares D, Mañá P, Goodyear M, Chow AM, Clavarino C, Huntington ND, Barnett L, Koentgen F, Tomioka R, Bernard CC, Freire-Garabal M, Reid HH. J Autoimmun; 2003 Dec 01; 21(4):339-51. PubMed ID: 14624757 [Abstract] [Full Text] [Related]
36. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O. J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550 [Abstract] [Full Text] [Related]
37. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model. Kap YS, van Driel N, Arends R, Rouwendal G, Verolin M, Blezer E, Lycke N, 't Hart BA. Clin Exp Immunol; 2015 Apr 26; 180(1):28-39. PubMed ID: 25393803 [Abstract] [Full Text] [Related]
38. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC. Nat Med; 1998 Jan 26; 4(1):78-83. PubMed ID: 9427610 [Abstract] [Full Text] [Related]
39. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Stefferl A, Schubart A, Storch2 M, Amini A, Mather I, Lassmann H, Linington C. J Immunol; 2000 Sep 01; 165(5):2859-65. PubMed ID: 10946319 [Abstract] [Full Text] [Related]